NeuroEM Therapeutics is a private company and, as such, does not publicly disclose its financial information. The Company has thus far been supported by funding from multiple NIH grants, a prominent Foundation, several Angel groups, and private/family office investors. NeuroEM is currently raising Series A funding for initiation of its Pivotal clinical trial.

NeuroEM Therapeutics, Inc. is a Qualified Small Business for the Small Business Capital Investment Incentive Program as Certified by the Arizona Commerce Authority. Investments may generate Arizona tax credits of up to 35 percent of the investment amount for qualified investors.